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The Authors Reply: We agree that both the An-
ticoagulants for Living Fetuses (ALIFE) study (Cur-
rent Controlled Trials number, ISRCTN58496168) 
and the Scottish Pregnancy Intervention Study 
(ISRCTNO6774126)1 have investigated a combina-
tion of low-molecular-weight heparin and aspirin, 
and that a detrimental effect of aspirin cannot be 
entirely ruled out. Therefore, studies of the effect 
of low-molecular-weight heparin alone in women 
with recurrent miscarriage would be interesting. 
We disagree that a double-blind design is always 
necessary. Rather, concealment of study-drug as-
signment is the quality item in randomized, con-
trolled trials that may lead to the most severely 
biased effect estimates if it is inadequate.2 In the 
ALIFE study, all randomly assigned women were 
offered similar standards of care, thus avoiding 
performance bias. The standard of care in the 
ALIFE study involved a low threshold for visits and 
ultrasonography in early pregnancy; these can be 
considered a form of psychological support.
Currently, no consensus exists on the definition 
of recurrent miscarriage. Guidelines published on 
this topic and their respective definitions vary 
with regard to the number of preceding miscar-
riages as well as the sequence of previous preg-
nancies. The American College of Obstetricians 
and Gynecologists defines recurrent miscarriage 
as two or more consecutive miscarriages, the Eu-
ropean Society of Human Reproduction and Em-
bryology defines it as three or more consecutive 
miscarriages, and the Royal College of Obstetri-
cians and Gynaecologists defines it as three or 
more miscarriages. This discrepancy is due to a 
lack of evidence with regard to the role of risk 
factors such as the number of preceding miscar-
riages. Maternal age has not been described in any 
of the above-mentioned guidelines. The discrep-
ancy in definition has led to an ongoing discussion 
regarding which couples should receive the diag-
nosis of recurrent miscarriage and when to start 
the diagnostic workup.
The potential dilutive effects of recruiting 
women with two miscarriages and advanced ma-
ternal age were fully taken into account when 
our sample-size calculation was performed. This 
consideration was mainly based on the study by 
Brigham et al.,3 a large cohort study based on the 
same patient group, including women with two 
miscarriages and advanced maternal age.
We agree with Visser et al. that a meta-analysis 
of data from individual patients could provide im-
portant information regarding a differential effect 
of therapy in women with a history of two rather 
than three miscarriages. In the ALIFE trial, the 
exclusion of women with “only” two preceding 
miscarriages or women 36 years of age or older 
would have resulted in a missed opportunity.
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Cost Consciousness and Medical Education
to the editor: We commend Cooke’s efforts in 
her Perspective article (April 8 issue)1 to increase 
readers’ awareness of the near-universal ignorance 
of actual costs associated with the delivery of 
medical care.2-4 This lack of cost awareness affects 
all other components of the price equation, ren-
dering us incapable of understanding the true 
economic value of medical care. It also makes 
us unable to engage efficiently in any potential 
negotiation.5 As end consumers, we as physi-
cians must educate ourselves to know better — 
prices will never drop (even if the true cost is 
low) because of our lack of cost consciousness. 
The asymmetry between physicians and adminis-
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trators in knowledge about costs mirrors the 
asymmetry between patients and physicians re-
garding information about medical care.
We must change the way we educate newer 
generations of health care providers, and educa-
tors themselves must be prepared to teach new 
guidelines. Innovation is needed, not just in terms 
of advanced technologies, research, and newer 
therapies, but also in the way we teach newer 
generations about proper business management 
and instill administrative survival skills. Medical 
schools and residency programs should leverage 
their curriculum with partner business schools 
to address these issues.
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to the editor: In addition to the three factors 
noted by Cooke, I wish to add that the extrava-
gant use of health care is being driven in many 
instances by the psychological comfort of physi-
cians. In teaching hospitals, blood transfusions 
and costly biologic agents are frequently admin-
istered so that the doctor will feel better. Exam-
ples include the use of blood and clotting factors 
before bedside procedures in patients with trivial 
abnormalities of coagulation, transfusions to “treat 
worrisome laboratory values” in the absence of 
clinical need, and the expanding use of extremely 
expensive biologic agents that are prescribed off-
label to reassure physicians. Such motivations are 
distinct from patient advocacy. When these ex-
penditures are multiplied by all specialties, the 
total is beyond staggering. Dealing with medical 
uncertainty is not easy, but the psychological com-
fort that physicians gain by pursuing every imag-
inable diagnosis or treatment is no justification 
for ruinous expenditures on health care. When 
placed in the greater context of health care avail-
able for most of the world’s population, the ex-
travagance is far beyond unjustifiable.
Walter Dzik, M.D.
Massachusetts General Hospital 
Boston, MA 
sdzik@partners.org
No potential conflict of interest relevant to this letter was re-
ported.
to the editor: Cooke rightly points at the mor-
al, societal, and economic reasons for educating 
students in medically sound strategies for cost 
containment, and we wholeheartedly support her 
argument for a value-based approach to choosing 
treatment. However, we do not agree that patient-
centered care contributes to increasing health care 
costs. In fact, patient-centered care might hold the 
solution.
We physicians conceive of ourselves as advo-
cates for each patient, whereas research shows that 
health care professionals agree little with patients 
and family caregivers on treatment goals.1,2 It is 
therefore a misconception that doctors know best 
what creates value for a patient. Patient-centered 
care, shared decision making, and collaborative 
goal setting can help us understand what a pa-
tient values most. Will this result in additional 
health care spending? We doubt it. Although 
strong evidence on the effectiveness of collabora-
tive goal setting is lacking,3 its promise for im-
proving cost-effectiveness is evident: it would do 
so first by increasing patient satisfaction and ad-
herence2,4 and second by ensuring that the lim-
ited available resources are allocated to the care 
that matters most to the patient.
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to the editor: Cooke believes that medical edu-
cators have a moral obligation to address cost, and 
I would argue that this should not be an issue 
whose discussion is left to the discretion of med-
ical educators. Education about cost should be 
standardized, integrated, and clearly outlined in 
the medical curriculum. Linking evidence-based 
medicine with economic evaluation and commu-
nication (negotiation) skills should be clearly 
highlighted in the curriculum. Recent research 
articles1,2 have addressed this concept and could 
be used as resources for students’ discussion.
In addition, Cooke did not highlight the im-
portance of patient education in reducing costs 
or the value of rehabilitation and preventive pro-
grams in minimizing the need for hospital care3 
— an important consideration for patients with 
diabetes, hypertension, chronic respiratory prob-
lems, or obesity, for example.4 Medical education 
should place more emphasis on patient education 
and preventive programs.
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the author replies: The correspondents all 
add important points to my brief essay in support 
of the contention that medical education should 
address cost. Rivas et al. note that it can be dif-
ficult to obtain information on charges. Further-
more, the weak relationship among what is 
charged, what is paid, and what a test or treat-
ment actually costs hinders the development of 
cost consciousness.1 Robben et al. challenge what 
they took to be my assertion that patient-centered-
ness increases the cost of care; I appreciate the 
opportunity to clarify. Like these correspondents, 
I find evidence that patient-centeredness may de-
crease the cost of care.2 However, if a “customer 
satisfaction” orientation is confused with patient-
centeredness and is compounded by lack of time 
for fully eliciting patients’ values and exploring 
risks and benefits, busy physicians may simply 
accede to requests for minimally beneficial care.3 
This is entirely different from shared decision 
making and collaborative goal setting.
Dzik calls our attention to the physician as 
the driver in wasteful care. In addition to order-
ing tests as a way of reducing psychological dis-
comfort associated with uncertainty, many phy-
sicians would implicate the tort system as a cause 
of wasteful “defensive medicine.”4 Azer correctly 
notes that innovative delivery systems that sup-
port patients’ self-management and matching pa-
tients’ needs with appropriate caregivers can pre-
vent the development of disease and provide care 
in settings outside the acute care hospital at 
lower cost.5
As we move to reform health care in the 
United States, there are substantial opportunities 
to build into medical education the knowledge 
and skills that are required for the provision of 
cost-conscious care. Imagine, for example, a com-
puterized order-entry system that displays the 
charge for each drug or test at the time that it is 
ordered and that informs the physician of the 
daily charges for each patient and the cost of the 
hospitalization, as compared with the average cost 
for the principal diagnosis-related group. How-
ever, other issues that these letters raise cannot be 
easily addressed in the inpatient setting. Learn-
ers following patients over time in a well-func-
tioning delivery system, whether it be an ac-
countable care organization or a patient-centered 
medical home in a “good medical neighbor-
hood,” will learn skills in shared decision mak-
ing, participate in collegial teams of health care 
professionals, and come to appreciate the bene-
fits of judiciously designed and collaboratively 
implemented diagnostic and therapeutic strate-
gies for patients and the health care system.
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University of California, San Francisco 
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The New England Journal of Medicine 
Downloaded from nejm.org at RADBOUD UNIVERSITEIT NIJMEGEN on July 12, 2012. For personal use only. No other uses without permission. 
 Copyright © 2010 Massachusetts Medical Society. All rights reserved. 
correspondence
n engl j med 363;9 nejm.org august 26, 2010 891
Since publication of her article, the author reports no further 
potential conflict of interest.
Robinson JC. Price transparency begins at home. Front 1. 
Health Serv Manage 2007;23:25-8.
O’Connor AM, Bennett CL, Stacey D, et al. Decision aids for 2. 
people facing health treatment or screening decisions. Cochrane 
Database Syst Rev 2009;3:CD001431.
Gellad ZF, Lyles KW. Direct-to-consumer advertising of phar-3. 
maceuticals. Am J Med 2007;120:475-80.
Hermer LD, Brody H. Defensive medicine, cost containment, 4. 
and reform. J Gen Intern Med 2010;25:470-3.
Grumbach K, Bodenheimer T, Grundy P. The outcomes of 5. 
implementing patient-centered medical home interventions: 
a review of the evidence on quality, access and costs from recent 
prospective evaluation trials, August 2009. Washington, DC: 
Patient-Centered Primary Care Collaborative, 2009. (Accessed 
August 5, 2010, at http://www.pcpcc.net/files/pcmh_evidence_ 
outcomes_2009.pdf.)
Reference Range for Cerebrospinal Fluid Opening Pressure  
in Children
To the Editor: A reference range for cerebrospi-
nal fluid (CSF) opening pressure in children un-
dergoing diagnostic lumbar puncture has not been 
established.1 The influence of age, body-mass in-
dex (BMI), and depth of sedation on opening pres-
sure in children is also uncertain.2
We conducted a 2-year, single-center prospec-
tive study of CSF opening pressure in children 
undergoing lumbar puncture as part of their rou-
tine clinical care. Our objective was to establish 
a useful, clinically relevant reference range for 
opening pressure and a threshold value for ab-
normally elevated opening pressure (in the 90th 
percentile or higher, defined a priori). Our refer-
ence group consisted of children between 1 and 18 
years of age, none of whom was taking a medi-
cation or had signs of a disease or condition that 
would alter opening pressure on lumbar puncture 
(e.g., papilledema, hydrocephalus, cerebral edema, 
Chiari malformation, meningitis, or use of diuret-
ics).  The procedure was performed with subjects 
in the lateral recumbent position, and the open-
ing pressure was measured with the use of a stan-
dard manometer. (For enrollment criteria, meth-
ods, and results, see the Supplementary Appendix, 
available with the full text of this letter at NEJM 
.org.) Reference-range parameters for opening 
pressure were determined with the use of stan-
dard descriptive statistics, whereas associations 
between age, BMI, and depth of sedation were 
determined using linear regression analysis.
We enrolled 472 subjects during the study pe-
riod, and 197 (41.7%) met the inclusion criteria for 
the reference-range population. The threshold for 
an abnormally elevated opening pressure, deter-
mined on the basis of the 90th percentile for all 
patients in the reference population, was 28 cm 
of water (Fig. 1A). The threshold for an abnor-
mally reduced pressure in the 10th percentile was 
11.5 cm of water. Subjects placed under moderate 
to deep sedation during lumbar puncture had a 
slightly higher opening pressure as compared 
with those not receiving any sedative medication 
(β = 3.459, P = 0.002) (Fig. 1B). Similar to studies 
in adults,3,4 our study showed a small yet statisti-
cally significant positive relationship between 
opening pressure and BMI (β = 0.313, P = 0.002) 
(Fig. 1C). Subject age was not associated with in-
creased opening pressure (P = 0.43) (Fig. 1D). Given 
the significant association between depth of se-
dation and BMI on opening pressure, a post-hoc 
analysis of opening pressure percentiles was cal-
culated for the 52 subjects who received minimal 
or no sedation and were not classified as obese, 
resulting in a 90th percentile of 25 cm of water.
This study systematically defined the reference 
range for CSF opening pressure and the thresh-
old value for abnormally elevated opening pres-
sure in a representative pediatric population (in 
whom evident pathology was excluded) undergo-
ing diagnostic lumbar puncture. It is our opinion 
that previous estimates of what constitutes an 
“abnormal” opening pressure, such as 20 cm of 
water,1,5 should be reconsidered, and that for most 
children an opening pressure above 28 cm of water 
should be considered elevated.
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